| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |